The SEC and DOJ have brought AI-washing cases against named founders and executives. Raz and Saniger both face charged securities-fraud and wire-fraud counts with stated maximum sentences of 20 years each, plus SEC civil relief requests. The cases remain allegations unless and until a court resolves them.
In brief: The SEC and DOJ charged Ilit Raz, CEO and founder of Joonko, in June 2024. The SEC and DOJ charged Albert Saniger, founder and former CEO of Nate Inc., in April 2025. DOJ releases for both matters state that the charged securities-fraud and wire-fraud counts each carry a maximum sentence of 20 years. A four-eyes approved, version-controlled record of what “AI-powered” means inside the company is one governance artifact, not a defense by itself.
For most founders, the mental model for a regulatory event is that the company is the defendant. That model is out of date. The two reference cases in AI-washing enforcement are both styled as actions against a named individual.
“Engaged in an old school fraud using new school buzzwords like ‘artificial intelligence’ and ‘automation.’” SEC, Press Release 2024-70, describing the alleged conduct of Ilit Raz, CEO and founder of Joonko Diversity Inc.
The SEC alleged Raz raised $21 million across 2021 and 2022 funding rounds by making false claims about customers, candidates, revenue, contracts, and AI/automation-related representations. The relief sought was a permanent injunction, civil money penalties, disgorgement, and an officer-and-director bar. The parallel DOJ case charged securities fraud and wire fraud.
Ten months later the enforcement posture escalated again. The SEC Saniger release alleged that Saniger raised more than $42 million from investors while falsely claiming Nate’s mobile shopping app used AI to complete purchases automatically, when the app allegedly relied on workers to perform the purchases manually. The parallel DOJ release charged securities fraud and wire fraud, and states that each count carries a maximum sentence of 20 years in prison.
The SEC’s parallel civil complaint seeks permanent injunctions, conduct-based injunctions, disgorgement with prejudgment interest, civil penalties, and an officer-and-director bar. These are allegations, not findings. The point for founders is narrower: investor-facing AI capability claims can become named-executive antifraud matters even before a company is public.
These are the two private-company fundraising reference points this page relies on. The Harvard Law School Forum on Corporate Governance reads the Saniger action as a DOJ move into criminal AI-washing enforcement. The AI-related executive enforcement universe is broader; for example, the Kubient/Roberts public-company matter is a separate fact pattern and is not the focus of this page.
The exposure is not an abstract regulatory fine against an entity. It is named, personal, and, in the Raz and Saniger matters, criminal as well as civil.
One structural point often missed by founders: SEC Rule 10b-5 and Section 17(a) claims can reach private placements. Pre-IPO does not mean out of scope. Both Joonko and Nate involved private fundraising allegations. The risk follows material investor representations, not only exchange-listed disclosure.
Founders using AI claims in a Series A or later fundraising process should expect harder questions from the board, counsel, investors, and D&O underwriters about what controls govern AI capability language in the pitch deck, website, data room, and investor updates.
The factual question is the same: show the record of how AI capability terms are defined and approved inside the company. A CEO who can produce a timestamped, versioned, approver-named record is answering that question with an artifact. A CEO who says “we’re careful about how we describe the product” is answering it with a sentence.
The calendar compounds the pressure. The Raz charges landed in June 2024. The Saniger charges landed in April 2025. The Harvard Corp Gov analysis reads Saniger as an escalation pattern rather than a one-off. For a founder with a 2026 fundraise, board meeting, or exit process on the runway, the record should predate the diligence request, not follow it.
Compliance Glossary is not a legal shield and no vendor-sold artifact is. It is one concrete governance record inside the broader disclosure-controls picture the SEC and DOJ staff are examining. The narrow job it does is to create an internal, verifiable answer to the question: who at the company approved what “AI-powered,” “automated,” “autonomous,” “machine learning,” or “large language model” means in our investor materials.
For current pricing, see the Atlassian Marketplace.
This article is informational and is not legal advice. Consult qualified securities counsel for disclosure decisions specific to your facts.
This page focuses on two private-company fundraising matters: the SEC and DOJ Raz/Joonko case and the SEC and DOJ Saniger/Nate case. It is not an exhaustive AI-related executive enforcement tracker; for example, the Kubient/Roberts public-company case is a separate fact pattern.
The SEC and DOJ Raz and Saniger matters involved private fundraising representations. That does not mean every private-company AI statement creates liability, but material investor statements about AI capability can be within SEC civil antifraud theories and DOJ criminal antifraud charges.
In the Raz matter the SEC sought permanent injunctive relief, disgorgement, civil money penalties, and an officer-and-director bar. In the Saniger matter the SEC sought permanent injunctions, conduct-based injunctions, disgorgement with prejudgment interest, civil penalties, and an officer-and-director bar. DOJ separately charged both Raz and Saniger with securities fraud and wire fraud. Actual outcomes depend on the court and case facts. Advancement, indemnification, and D&O coverage are policy- and jurisdiction-specific questions for counsel.
A four-eyes approved, version-controlled glossary of AI capability terms used in investor materials creates an internal governance record that the meaning of those terms was reviewed and approved at the company. That is one artifact that may support a reasonable-care narrative. It is not a legal shield. Whether scienter can be challenged is a question for securities counsel on the specific facts.
Last verified: 2026-06-22. Sources checked: SEC Press Release 2024-70 on Joonko/Raz, DOJ Raz release, SEC v. Saniger litigation release, DOJ Saniger release, the Harvard Law School Forum Saniger analysis, SEC Kubient/Roberts release, and DOJ Roberts sentencing release.
For current pricing, see the Atlassian Marketplace.
Evaluate in Confluence Read the Security Whitepaper